MUMBAI: Pune-based Serum Institute, credited with affordable and innovative therapies like pneumonia and dengue monoclonal vaccines, plans to price the proposed Covid-19 vaccine at around Rs 1,000 per dose in India. Serum is one of the global manufacturers that is putting its weight behind an Oxford University-led consortium, which announced the start of human clinical trials on April 23 and is one of the first such projects to get underway globally. “We hope to start trials in India from May, with a few hundred patients, and expect to roll out the vaccine by September–October, if the trials are successful. We are planning to make the vaccine available at an affordable price of around Rs 1,000 in India, which will take into account costs (for us)”, Serum Institute CEO and promoter Adar Poonawalla told TOI. The pricing in India, he said, is expected to be substantially lower than the global one as in the case of other vaccines like MMR (measles, mumps, and rubella) which are available at over 10 times the India price in countries like UK. “We are not waiting for the trials to get over in September in UK, and then start production here. The decision—at our own… Read full this story
- Joe Biden vows 100 million Covid-19 vaccinations in first 100 days of administration
- Biden Vows to Get 100Mln COVID-19 Vaccine Shots in First 100 Days of Presidency
- Gearing for first phase of COVID-19 vaccine shots, cold chains being put in place
- Italy plans 202 million COVID-19 vaccine doses
- Will the Covid-19 vaccine shots be long-lasting? Here’s what US vaccine chief hints
- Biden vows 100 million Covid-19 vaccinations in first 100 days
- When Can You Get The COVID-19 Vaccine?
- Britain Officially Launches COVID-19 Vaccination Drive
- Britain Makes Final Preparations for First Round of COVID-19 Vaccinations
- Won’t force Americans to take COVID-19 vaccine: Biden
- COVID-19 vaccine: States that are conducting phase-3 trials of Covaxin
- Britain Becomes 1st Nation to Approve Pfizer COVID-19 Vaccine
- Chinese-made COVID-19 Vaccine Nearly 90% Effective, UAE Says
- 'Vaccine Nationalism' Leaves World’s Poorest Nations Unable to Secure COVID-19 Vaccine, UN Chief Says
- US Allows Emergency COVID-19 Vaccine in Bid to End Pandemic
- Vietnam may distribute indigenous Covid-19 vaccine next May
- EU Leader Hopes COVID-19 Vaccinations Start in December
- China Gave COVID-19 Vaccine Candidate to N. Korea's Kim, US Analyst Says
- Hackers Targeting COVID-19 Vaccine Operations, IBM Warns
- Australia Abandons COVID-19 Vaccine Trials After False Positive HIV Results
Pune company plans to ready 20-40 million Covid-19 vaccine shots for launch by September-October have 378 words, post on timesofindia.indiatimes.com at April 27, 2020. This is cached page on The Best Articles. If you want remove this page, please contact us.